"","ID","Description","GeneRatio","BgRatio","pvalue","p.adjust","qvalue","geneID","Count"
"R-HSA-212436","R-HSA-212436","Generic Transcription Pathway","20/29","481/2914",3.67614369184433e-10,1.58489894638038e-07,1.04173566448965e-07,"MAPK1/TP53/SMAD2/MAPK14/SIRT1/CSNK2A1/CDK2/MAPK3/SMAD3/STK11/NR0B2/YY1/TWIST1/NR2C2AP/MED1/NOTCH1/CTNNB1/PPP2R5C/HDAC1/ZNF521",20
"R-HSA-73857","R-HSA-73857","RNA Polymerase II Transcription","20/29","499/2914",7.30368178055476e-10,1.58489894638038e-07,1.04173566448965e-07,"MAPK1/TP53/SMAD2/MAPK14/SIRT1/CSNK2A1/CDK2/MAPK3/SMAD3/STK11/NR0B2/YY1/TWIST1/NR2C2AP/MED1/NOTCH1/CTNNB1/PPP2R5C/HDAC1/ZNF521",20
"R-HSA-1266738","R-HSA-1266738","Developmental Biology","16/29","397/2914",1.31991370850043e-07,1.90947516496396e-05,1.25507584211796e-05,"MAPK1/STAT3/CEBPB/SMAD2/MAPK14/CEBPA/CSNK2A1/CDK2/MAPK3/SMAD3/YY1/MED1/NOTCH1/PAK1/CTNNB1/ROCK2",16
"R-HSA-195258","R-HSA-195258","RHO GTPase Effectors","8/29","130/2914",2.46003478473657e-05,0.00221227995805078,0.00145410591470231,"MAPK1/MAPK14/MAPK3/PLK1/PAK1/CTNNB1/PPP2R5C/ROCK2",8
"R-HSA-5633007","R-HSA-5633007","Regulation of TP53 Activity","7/29","95/2914",2.72112757892552e-05,0.00221227995805078,0.00145410591470231,"TP53/MAPK14/CSNK2A1/CDK2/STK11/PPP2R5C/HDAC1",7
"R-HSA-445144","R-HSA-445144","Signal transduction by L1","4/29","20/2914",3.43718569957949e-05,0.00221227995805078,0.00145410591470231,"MAPK1/CSNK2A1/MAPK3/PAK1",4
"R-HSA-2559583","R-HSA-2559583","Cellular Senescence","7/29","99/2914",3.56819348072706e-05,0.00221227995805078,0.00145410591470231,"MAPK1/TP53/STAT3/CEBPB/MAPK14/CDK2/MAPK3",7
"R-HSA-2262752","R-HSA-2262752","Cellular responses to stress","9/29","187/2914",4.96705119297545e-05,0.0026073456396042,0.00171377799741144,"MAPK1/TP53/HIF1A/STAT3/CEBPB/MAPK14/SIRT1/CDK2/MAPK3",9
"R-HSA-8953897","R-HSA-8953897","Cellular responses to external stimuli","9/29","189/2914",5.40693796231285e-05,0.0026073456396042,0.00171377799741144,"MAPK1/TP53/HIF1A/STAT3/CEBPB/MAPK14/SIRT1/CDK2/MAPK3",9
"R-HSA-2559582","R-HSA-2559582","Senescence-Associated Secretory Phenotype (SASP)","5/29","45/2914",6.30668128286157e-05,0.00273709967676192,0.00179906381858472,"MAPK1/STAT3/CEBPB/CDK2/MAPK3",5
"R-HSA-9614085","R-HSA-9614085","FOXO-mediated transcription","5/29","49/2914",9.57438703718057e-05,0.00367253511434695,0.00241391466405051,"SMAD2/SIRT1/SMAD3/STK11/HDAC1",5
"R-HSA-450341","R-HSA-450341","Activation of the AP-1 family of transcription factors","3/29","10/2914",0.000101544749705446,0.00367253511434695,0.00241391466405051,"MAPK1/MAPK14/MAPK3",3
"R-HSA-9616222","R-HSA-9616222","Transcriptional regulation of granulopoiesis","4/29","27/2914",0.000118637994555281,0.00396068381823014,0.00260331145947215,"STAT3/CEBPB/CEBPA/CDK2",4
"R-HSA-6804756","R-HSA-6804756","Regulation of TP53 Activity through Phosphorylation","5/29","56/2914",0.000182713265355383,0.00566411122601687,0.00372295450460968,"TP53/MAPK14/CSNK2A1/CDK2/STK11",5
"R-HSA-6807070","R-HSA-6807070","PTEN Regulation","5/29","59/2914",0.000234543422728405,0.0063703667280526,0.00418716804099504,"MAPK1/TP53/CSNK2A1/MAPK3/HDAC1",5
"R-HSA-8943724","R-HSA-8943724","Regulation of PTEN gene transcription","4/29","32/2914",0.000234852229605626,0.0063703667280526,0.00418716804099504,"MAPK1/TP53/MAPK3/HDAC1",4
"R-HSA-5675221","R-HSA-5675221","Negative regulation of MAPK pathway","4/29","34/2914",0.000298730840893054,0.00762642264397561,0.00501275900198251,"MAPK1/DUSP10/MAPK3/PPP2R5C",4
"R-HSA-69278","R-HSA-69278","Cell Cycle, Mitotic","8/29","191/2914",0.000381911585230231,0.00920831266610669,0.00605251693552004,"MAPK1/TP53/CSNK2A1/CDK2/MAPK3/PLK1/PPP2R5C/HDAC1",8
"R-HSA-5668599","R-HSA-5668599","RHO GTPases Activate NADPH Oxidases","3/29","16/2914",0.000455176995602401,0.010397200846918,0.00683395932455683,"MAPK1/MAPK14/MAPK3",3
"R-HSA-8940973","R-HSA-8940973","RUNX2 regulates osteoblast differentiation","3/29","19/2914",0.000771936381652332,0.0154012178872321,0.010123041589716,"MAPK1/MAPK3/ZNF521",3
"R-HSA-9615017","R-HSA-9615017","FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes","3/29","19/2914",0.000771936381652332,0.0154012178872321,0.010123041589716,"SMAD2/SMAD3/HDAC1",3
"R-HSA-5663202","R-HSA-5663202","Diseases of signal transduction","9/29","268/2914",0.000790754598432134,0.0154012178872321,0.010123041589716,"MAPK1/STAT3/SMAD2/MAPK3/SMAD3/NOTCH1/CTNNB1/PPP2R5C/HDAC1",9
"R-HSA-2559580","R-HSA-2559580","Oxidative Stress Induced Senescence","4/29","44/2914",0.000816193574668981,0.0154012178872321,0.010123041589716,"MAPK1/TP53/MAPK14/MAPK3",4
"R-HSA-2173795","R-HSA-2173795","Downregulation of SMAD2/3:SMAD4 transcriptional activity","3/29","20/2914",0.000902094827179957,0.0163128814581709,0.0107222674634109,"SMAD2/SMAD3/HDAC1",3
"R-HSA-198753","R-HSA-198753","ERK/MAPK targets","3/29","21/2914",0.00104541603649165,0.018148422393495,0.0119287471953363,"MAPK1/MAPK14/MAPK3",3
"R-HSA-109606","R-HSA-109606","Intrinsic Pathway for Apoptosis","4/29","49/2914",0.00123074160022092,0.0202154083817813,0.013287353071702,"MAPK1/TP53/STAT3/MAPK3",4
"R-HSA-194315","R-HSA-194315","Signaling by Rho GTPases","8/29","228/2914",0.00125764061361312,0.0202154083817813,0.013287353071702,"MAPK1/MAPK14/MAPK3/PLK1/PAK1/CTNNB1/PPP2R5C/ROCK2",8
"R-HSA-112409","R-HSA-112409","RAF-independent MAPK1/3 activation","3/29","23/2914",0.00137352998659414,0.0205067945456549,0.0134788778119633,"MAPK1/DUSP10/MAPK3",3
"R-HSA-2559585","R-HSA-2559585","Oncogene Induced Senescence","3/29","23/2914",0.00137352998659414,0.0205067945456549,0.0134788778119633,"MAPK1/TP53/MAPK3",3
"R-HSA-198725","R-HSA-198725","Nuclear Events (kinase and transcription factor activation)","3/29","24/2914",0.0015592723963286,0.0205067945456549,0.0134788778119633,"MAPK1/MAPK14/MAPK3",3
"R-HSA-2173796","R-HSA-2173796","SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription","3/29","24/2914",0.0015592723963286,0.0205067945456549,0.0134788778119633,"SMAD2/SMAD3/HDAC1",3
"R-HSA-8941326","R-HSA-8941326","RUNX2 regulates bone development","3/29","24/2914",0.0015592723963286,0.0205067945456549,0.0134788778119633,"MAPK1/MAPK3/ZNF521",3
"R-HSA-982772","R-HSA-982772","Growth hormone receptor signaling","3/29","24/2914",0.0015592723963286,0.0205067945456549,0.0134788778119633,"MAPK1/STAT3/MAPK3",3
"R-HSA-373760","R-HSA-373760","L1CAM interactions","4/29","53/2914",0.0016547145960336,0.0205184609908167,0.0134865460308303,"MAPK1/CSNK2A1/MAPK3/PAK1",4
"R-HSA-8878159","R-HSA-8878159","Transcriptional regulation by RUNX3","4/29","53/2914",0.0016547145960336,0.0205184609908167,0.0134865460308303,"TP53/SMAD3/NOTCH1/CTNNB1",4
"R-HSA-1640170","R-HSA-1640170","Cell Cycle","8/29","249/2914",0.00223096264973182,0.0268954941662114,0.0176780958502141,"MAPK1/TP53/CSNK2A1/CDK2/MAPK3/PLK1/PPP2R5C/HDAC1",8
"R-HSA-3700989","R-HSA-3700989","Transcriptional Regulation by TP53","7/29","194/2914",0.00230627279767714,0.0270519565997805,0.0177809367900571,"TP53/MAPK14/CSNK2A1/CDK2/STK11/PPP2R5C/HDAC1",7
"R-HSA-6804757","R-HSA-6804757","Regulation of TP53 Degradation","3/29","29/2914",0.00272237723059098,0.0291448267931996,0.0191565560537402,"TP53/CDK2/PPP2R5C",3
"R-HSA-6806003","R-HSA-6806003","Regulation of TP53 Expression and Degradation","3/29","29/2914",0.00272237723059098,0.0291448267931996,0.0191565560537402,"TP53/CDK2/PPP2R5C",3
"R-HSA-109581","R-HSA-109581","Apoptosis","5/29","101/2914",0.0027725577598772,0.0291448267931996,0.0191565560537402,"MAPK1/TP53/STAT3/MAPK3/CTNNB1",5
"R-HSA-8878166","R-HSA-8878166","Transcriptional regulation by RUNX2","4/29","62/2914",0.00296280063331982,0.0291448267931996,0.0191565560537402,"MAPK1/MAPK3/TWIST1/ZNF521",4
"R-HSA-2871796","R-HSA-2871796","FCERI mediated MAPK activation","3/29","30/2914",0.00300470079191785,0.0291448267931996,0.0191565560537402,"MAPK1/MAPK3/PAK1",3
"R-HSA-390466","R-HSA-390466","Chaperonin-mediated protein folding","3/29","30/2914",0.00300470079191785,0.0291448267931996,0.0191565560537402,"TP53/STAT3/CSNK2A1",3
"R-HSA-450282","R-HSA-450282","MAPK targets/ Nuclear events mediated by MAP kinases","3/29","30/2914",0.00300470079191785,0.0291448267931996,0.0191565560537402,"MAPK1/MAPK14/MAPK3",3
"R-HSA-5357801","R-HSA-5357801","Programmed Cell Death","5/29","103/2914",0.00302192904537784,0.0291448267931996,0.0191565560537402,"MAPK1/TP53/STAT3/MAPK3/CTNNB1",5
"R-HSA-157118","R-HSA-157118","Signaling by NOTCH","5/29","104/2914",0.00315256620774045,0.0297437768295512,0.0195502389541799,"TP53/HIF1A/SMAD3/NOTCH1/HDAC1",5
"R-HSA-68886","R-HSA-68886","M Phase","5/29","105/2914",0.00328726846386713,0.029877855681528,0.0196383674258891,"MAPK1/CSNK2A1/MAPK3/PLK1/PPP2R5C",5
"R-HSA-391251","R-HSA-391251","Protein folding","3/29","31/2914",0.00330446330118282,0.029877855681528,0.0196383674258891,"TP53/STAT3/CSNK2A1",3
"R-HSA-3371453","R-HSA-3371453","Regulation of HSF1-mediated heat shock response","3/29","32/2914",0.0036220092741046,0.0320806535706408,0.0210862408868388,"MAPK1/SIRT1/MAPK3",3
"R-HSA-8939211","R-HSA-8939211","ESR-mediated signaling","5/29","108/2914",0.0037164979027624,0.0322592017959776,0.0212035985610234,"MAPK1/MAPK3/YY1/MED1/HDAC1",5
"R-HSA-187687","R-HSA-187687","Signalling to ERKs","3/29","33/2914",0.00395766925047827,0.0323267799277292,0.0212480168819176,"MAPK1/MAPK14/MAPK3",3
"R-HSA-68875","R-HSA-68875","Mitotic Prophase","3/29","33/2914",0.00395766925047827,0.0323267799277292,0.0212480168819176,"MAPK1/MAPK3/PLK1",3
"R-HSA-111458","R-HSA-111458","Formation of apoptosome","2/29","10/2914",0.00409671174199333,0.0323267799277292,0.0212480168819176,"MAPK1/MAPK3",2
"R-HSA-74749","R-HSA-74749","Signal attenuation","2/29","10/2914",0.00409671174199333,0.0323267799277292,0.0212480168819176,"MAPK1/MAPK3",2
"R-HSA-9627069","R-HSA-9627069","Regulation of the apoptosome activity","2/29","10/2914",0.00409671174199333,0.0323267799277292,0.0212480168819176,"MAPK1/MAPK3",2
"R-HSA-187037","R-HSA-187037","Signaling by NTRK1 (TRKA)","4/29","70/2914",0.00460875124976638,0.0357178221856895,0.0234769095617799,"MAPK1/STAT3/MAPK14/MAPK3",4
"R-HSA-452723","R-HSA-452723","Transcriptional regulation of pluripotent stem cells","2/29","11/2914",0.00497627215191163,0.0366051205750787,0.024060120484711,"STAT3/SMAD2",2
"R-HSA-5627117","R-HSA-5627117","RHO GTPases Activate ROCKs","2/29","11/2914",0.00497627215191163,0.0366051205750787,0.024060120484711,"PAK1/ROCK2",2
"R-HSA-6804116","R-HSA-6804116","TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest","2/29","11/2914",0.00497627215191163,0.0366051205750787,0.024060120484711,"TP53/CDK2",2
"R-HSA-2173793","R-HSA-2173793","Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer","3/29","36/2914",0.00507643460464245,0.0367195436402471,0.0241353294361071,"SMAD2/SMAD3/HDAC1",3
"R-HSA-195253","R-HSA-195253","Degradation of beta-catenin by the destruction complex","3/29","37/2914",0.00548758584645575,0.0390257403026157,0.0256511657094563,"CTNNB1/PPP2R5C/HDAC1",3
"R-HSA-1257604","R-HSA-1257604","PIP3 activates AKT signaling","6/29","172/2914",0.0058972762730026,0.0390257403026157,0.0256511657094563,"MAPK1/TP53/CSNK2A1/MAPK3/PPP2R5C/HDAC1",6
"R-HSA-111461","R-HSA-111461","Cytochrome c-mediated apoptotic response","2/29","12/2914",0.00593478999993695,0.0390257403026157,0.0256511657094563,"MAPK1/MAPK3",2
"R-HSA-1502540","R-HSA-1502540","Signaling by Activin","2/29","12/2914",0.00593478999993695,0.0390257403026157,0.0256511657094563,"SMAD2/SMAD3",2
"R-HSA-170968","R-HSA-170968","Frs2-mediated activation","2/29","12/2914",0.00593478999993695,0.0390257403026157,0.0256511657094563,"MAPK1/MAPK3",2
"R-HSA-202670","R-HSA-202670","ERKs are inactivated","2/29","12/2914",0.00593478999993695,0.0390257403026157,0.0256511657094563,"MAPK1/MAPK3",2
"R-HSA-5688426","R-HSA-5688426","Deubiquitination","5/29","124/2914",0.00671633312602891,0.0430190522558395,0.0282759232629942,"TP53/HIF1A/SMAD2/SMAD3/YY1",5
"R-HSA-2122947","R-HSA-2122947","NOTCH1 Intracellular Domain Regulates Transcription","3/29","40/2914",0.00683943457523715,0.0430190522558395,0.0282759232629942,"HIF1A/NOTCH1/HDAC1",3
"R-HSA-381340","R-HSA-381340","Transcriptional regulation of white adipocyte differentiation","3/29","40/2914",0.00683943457523715,0.0430190522558395,0.0282759232629942,"CEBPB/CEBPA/MED1",3
"R-HSA-169893","R-HSA-169893","Prolonged ERK activation events","2/29","13/2914",0.00697071712721198,0.0432184461887143,0.0284069825785631,"MAPK1/MAPK3",2
"R-HSA-5689880","R-HSA-5689880","Ub-specific processing proteases","4/29","80/2914",0.00742099695232486,0.0438477064874902,0.0288205880623572,"TP53/HIF1A/SMAD2/SMAD3",4
"R-HSA-1295596","R-HSA-1295596","Spry regulation of FGF signaling","2/29","14/2914",0.00808252654147286,0.0438477064874902,0.0288205880623572,"MAPK1/MAPK3",2
"R-HSA-4839743","R-HSA-4839743","phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex","2/29","14/2914",0.00808252654147286,0.0438477064874902,0.0288205880623572,"CTNNB1/PPP2R5C",2
"R-HSA-5339716","R-HSA-5339716","Misspliced GSK3beta mutants stabilize beta-catenin","2/29","14/2914",0.00808252654147286,0.0438477064874902,0.0288205880623572,"CTNNB1/PPP2R5C",2
"R-HSA-5358747","R-HSA-5358747","S33 mutants of beta-catenin aren't phosphorylated","2/29","14/2914",0.00808252654147286,0.0438477064874902,0.0288205880623572,"CTNNB1/PPP2R5C",2
"R-HSA-5358749","R-HSA-5358749","S37 mutants of beta-catenin aren't phosphorylated","2/29","14/2914",0.00808252654147286,0.0438477064874902,0.0288205880623572,"CTNNB1/PPP2R5C",2
"R-HSA-5358751","R-HSA-5358751","S45 mutants of beta-catenin aren't phosphorylated","2/29","14/2914",0.00808252654147286,0.0438477064874902,0.0288205880623572,"CTNNB1/PPP2R5C",2
"R-HSA-5358752","R-HSA-5358752","T41 mutants of beta-catenin aren't phosphorylated","2/29","14/2914",0.00808252654147286,0.0438477064874902,0.0288205880623572,"CTNNB1/PPP2R5C",2
"R-HSA-6804758","R-HSA-6804758","Regulation of TP53 Activity through Acetylation","2/29","14/2914",0.00808252654147286,0.0438477064874902,0.0288205880623572,"TP53/HDAC1",2
"R-HSA-9617828","R-HSA-9617828","FOXO-mediated transcription of cell cycle genes","2/29","14/2914",0.00808252654147286,0.0438477064874902,0.0288205880623572,"SMAD2/SMAD3",2
"R-HSA-2029482","R-HSA-2029482","Regulation of actin dynamics for phagocytic cup formation","3/29","43/2914",0.00837379429663351,0.0448669966017154,0.0294905556125755,"MAPK1/MAPK3/PAK1",3
"R-HSA-4420097","R-HSA-4420097","VEGFA-VEGFR2 Pathway","4/29","85/2914",0.00917931427622787,0.0473249539120876,0.0311061423967396,"MAPK14/PAK1/CTNNB1/ROCK2",4
"R-HSA-1181150","R-HSA-1181150","Signaling by NODAL","2/29","15/2914",0.00926871217172224,0.0473249539120876,0.0311061423967396,"SMAD2/SMAD3",2
"R-HSA-432142","R-HSA-432142","Platelet sensitization by LDL","2/29","15/2914",0.00926871217172224,0.0473249539120876,0.0311061423967396,"MAPK14/PPP2R5C",2
"R-HSA-9008059","R-HSA-9008059","Interleukin-37 signaling","2/29","15/2914",0.00926871217172224,0.0473249539120876,0.0311061423967396,"STAT3/SMAD3",2
"R-HSA-9006931","R-HSA-9006931","Signaling by Nuclear Receptors","5/29","136/2914",0.00987695392103777,0.0498441628108185,0.032761989138326,"MAPK1/MAPK3/YY1/MED1/HDAC1",5
"R-HSA-383280","R-HSA-383280","Nuclear Receptor transcription pathway","3/29","46/2914",0.010096206367551,0.0502537936919728,0.0330312347575179,"NR0B2/NR2C2AP/MED1",3
"R-HSA-111471","R-HSA-111471","Apoptotic factor-mediated response","2/29","16/2914",0.0105277886254536,0.0502537936919728,0.0330312347575179,"MAPK1/MAPK3",2
"R-HSA-196299","R-HSA-196299","Beta-catenin phosphorylation cascade","2/29","16/2914",0.0105277886254536,0.0502537936919728,0.0330312347575179,"CTNNB1/PPP2R5C",2
"R-HSA-8852276","R-HSA-8852276","The role of GTSE1 in G2/M progression after G2 checkpoint","2/29","16/2914",0.0105277886254536,0.0502537936919728,0.0330312347575179,"TP53/PLK1",2
"R-HSA-8848021","R-HSA-8848021","Signaling by PTK6","3/29","47/2914",0.0107129616454713,0.0502537936919728,0.0330312347575179,"HIF1A/STAT3/CDK2",3
"R-HSA-9006927","R-HSA-9006927","Signaling by Non-Receptor Tyrosine Kinases","3/29","47/2914",0.0107129616454713,0.0502537936919728,0.0330312347575179,"HIF1A/STAT3/CDK2",3
"R-HSA-166520","R-HSA-166520","Signaling by NTRKs","4/29","89/2914",0.0107686700768513,0.0502537936919728,0.0330312347575179,"MAPK1/STAT3/MAPK14/MAPK3",4
"R-HSA-5250941","R-HSA-5250941","Negative epigenetic regulation of rRNA expression","2/29","17/2914",0.0118582909484029,0.0534610991774543,0.0351393593914386,"SIRT1/HDAC1",2
"R-HSA-9013695","R-HSA-9013695","NOTCH4 Intracellular Domain Regulates Transcription","2/29","17/2914",0.0118582909484029,0.0534610991774543,0.0351393593914386,"SMAD3/NOTCH1",2
"R-HSA-3371556","R-HSA-3371556","Cellular response to heat stress","3/29","49/2914",0.0120113220442727,0.0534610991774543,0.0351393593914386,"MAPK1/SIRT1/MAPK3",3
"R-HSA-9018519","R-HSA-9018519","Estrogen-dependent gene expression","3/29","49/2914",0.0120113220442727,0.0534610991774543,0.0351393593914386,"YY1/MED1/HDAC1",3
"R-HSA-194138","R-HSA-194138","Signaling by VEGF","4/29","92/2914",0.0120718611045865,0.0534610991774543,0.0351393593914386,"MAPK14/PAK1/CTNNB1/ROCK2",4
"R-HSA-9006925","R-HSA-9006925","Intracellular signaling by second messengers","6/29","201/2914",0.0124310281307271,0.0544956182700561,0.0358193367722174,"MAPK1/TP53/CSNK2A1/MAPK3/PPP2R5C/HDAC1",6
"R-HSA-6785807","R-HSA-6785807","Interleukin-4 and Interleukin-13 signaling","4/29","94/2914",0.0129951338879674,0.0558443343974028,0.0367058322136701,"TP53/HIF1A/STAT3/TWIST1",4
"R-HSA-449147","R-HSA-449147","Signaling by Interleukins","8/29","332/2914",0.0129960317376444,0.0558443343974028,0.0367058322136701,"MAPK1/TP53/HIF1A/STAT3/MAPK14/MAPK3/SMAD3/TWIST1",8
"R-HSA-69273","R-HSA-69273","Cyclin A/B1/B2 associated events during G2/M transition","2/29","18/2914",0.0132587743868025,0.055867068775459,0.036720775256244,"CDK2/PLK1",2
"R-HSA-881907","R-HSA-881907","Gastrin-CREB signalling pathway via PKC and MAPK","2/29","18/2914",0.0132587743868025,0.055867068775459,0.036720775256244,"MAPK1/MAPK3",2
"R-HSA-400253","R-HSA-400253","Circadian Clock","3/29","52/2914",0.0141229565632761,0.0589361841198251,0.0387380691158686,"HIF1A/SIRT1/MED1",3
"R-HSA-1538133","R-HSA-1538133","G0 and Early G1","2/29","19/2914",0.0147278141521143,0.0608749651620723,0.0400124073706563,"CDK2/HDAC1",2
"R-HSA-73854","R-HSA-73854","RNA Polymerase I Promoter Clearance","2/29","20/2914",0.0162640051882181,0.0659680210438004,0.0433600138318455,"MAPK3/HDAC1",2
"R-HSA-73864","R-HSA-73864","RNA Polymerase I Transcription","2/29","20/2914",0.0162640051882181,0.0659680210438004,0.0433600138318455,"MAPK3/HDAC1",2
"R-HSA-68877","R-HSA-68877","Mitotic Prometaphase","3/29","56/2914",0.01724929701363,0.0693166194806982,0.0455610086812254,"CSNK2A1/PLK1/PPP2R5C",3
"R-HSA-201722","R-HSA-201722","Formation of the beta-catenin:TCF transactivating complex","2/29","22/2914",0.0195323181305375,0.074359877795204,0.0488758837800152,"CTNNB1/HDAC1",2
"R-HSA-2173788","R-HSA-2173788","Downregulation of TGF-beta receptor signaling","2/29","22/2914",0.0195323181305375,0.074359877795204,0.0488758837800152,"SMAD2/SMAD3",2
"R-HSA-442742","R-HSA-442742","CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling","2/29","22/2914",0.0195323181305375,0.074359877795204,0.0488758837800152,"MAPK1/MAPK3",2
"R-HSA-525793","R-HSA-525793","Myogenesis","2/29","22/2914",0.0195323181305375,0.074359877795204,0.0488758837800152,"MAPK14/CTNNB1",2
"R-HSA-69563","R-HSA-69563","p53-Dependent G1 DNA Damage Response","2/29","22/2914",0.0195323181305375,0.074359877795204,0.0488758837800152,"TP53/CDK2",2
"R-HSA-69580","R-HSA-69580","p53-Dependent G1/S DNA damage checkpoint","2/29","22/2914",0.0195323181305375,0.074359877795204,0.0488758837800152,"TP53/CDK2",2
"R-HSA-450294","R-HSA-450294","MAP kinase activation","3/29","60/2914",0.0207354813173648,0.0776064805485315,0.0510098380515451,"MAPK1/MAPK14/MAPK3",3
"R-HSA-201681","R-HSA-201681","TCF dependent signaling in response to WNT","4/29","108/2914",0.0207427459530637,0.0776064805485315,0.0510098380515451,"CSNK2A1/CTNNB1/PPP2R5C/HDAC1",4
"R-HSA-1912408","R-HSA-1912408","Pre-NOTCH Transcription and Translation","2/29","23/2914",0.0212617265251987,0.0788682847174039,0.0518392072724144,"TP53/NOTCH1",2
"R-HSA-2029480","R-HSA-2029480","Fcgamma receptor (FCGR) dependent phagocytosis","3/29","62/2914",0.0226145449091888,0.081940515545078,0.0538585489030224,"MAPK1/MAPK3/PAK1",3
"R-HSA-983231","R-HSA-983231","Factors involved in megakaryocyte development and platelet production","3/29","62/2914",0.0226145449091888,0.081940515545078,0.0538585489030224,"TP53/CDK2/HDAC1",3
"R-HSA-2559586","R-HSA-2559586","DNA Damage/Telomere Stress Induced Senescence","2/29","24/2914",0.0230528587187324,0.081940515545078,0.0538585489030224,"TP53/CDK2",2
"R-HSA-69615","R-HSA-69615","G1/S DNA Damage Checkpoints","2/29","24/2914",0.0230528587187324,0.081940515545078,0.0538585489030224,"TP53/CDK2",2
"R-HSA-9634638","R-HSA-9634638","Estrogen-dependent nuclear events downstream of ESR-membrane signaling","2/29","24/2914",0.0230528587187324,0.081940515545078,0.0538585489030224,"MAPK1/MAPK3",2
"R-HSA-109582","R-HSA-109582","Hemostasis","7/29","298/2914",0.0235265719496931,0.081940515545078,0.0538585489030224,"MAPK1/TP53/MAPK14/CDK2/MAPK3/PPP2R5C/HDAC1",7
"R-HSA-170834","R-HSA-170834","Signaling by TGF-beta Receptor Complex","3/29","63/2914",0.0235881744555353,0.081940515545078,0.0538585489030224,"SMAD2/SMAD3/HDAC1",3
"R-HSA-1643685","R-HSA-1643685","Disease","9/29","443/2914",0.0236003789012322,0.081940515545078,0.0538585489030224,"MAPK1/STAT3/SMAD2/MAPK3/SMAD3/NOTCH1/CTNNB1/PPP2R5C/HDAC1",9
"R-HSA-1980143","R-HSA-1980143","Signaling by NOTCH1","3/29","64/2914",0.0245845560444574,0.082507723134381,0.054231367861793,"HIF1A/NOTCH1/HDAC1",3
"R-HSA-448424","R-HSA-448424","Interleukin-17 signaling","3/29","64/2914",0.0245845560444574,0.082507723134381,0.054231367861793,"MAPK1/MAPK14/MAPK3",3
"R-HSA-69620","R-HSA-69620","Cell Cycle Checkpoints","4/29","114/2914",0.0247855156091967,0.082507723134381,0.054231367861793,"TP53/CDK2/PLK1/PPP2R5C",4
"R-HSA-456926","R-HSA-456926","Thrombin signalling through proteinase activated receptors (PARs)","2/29","25/2914",0.0249044049092256,0.082507723134381,0.054231367861793,"MAPK1/MAPK3",2
"R-HSA-5218920","R-HSA-5218920","VEGFR2 mediated vascular permeability","2/29","25/2914",0.0249044049092256,0.082507723134381,0.054231367861793,"PAK1/CTNNB1",2
"R-HSA-5663213","R-HSA-5663213","RHO GTPases Activate WASPs and WAVEs","2/29","25/2914",0.0249044049092256,0.082507723134381,0.054231367861793,"MAPK1/MAPK3",2
"R-HSA-69275","R-HSA-69275","G2/M Transition","3/29","66/2914",0.0266455935812683,0.0875018193786953,0.0575139293029988,"TP53/CDK2/PLK1",3
"R-HSA-350054","R-HSA-350054","Notch-HLH transcription pathway","2/29","26/2914",0.0268150736805679,0.0875018193786953,0.0575139293029988,"NOTCH1/HDAC1",2
"R-HSA-5654732","R-HSA-5654732","Negative regulation of FGFR3 signaling","2/29","27/2914",0.0287835917861783,0.0925790345602988,0.0608511238560295,"MAPK1/MAPK3",2
"R-HSA-453274","R-HSA-453274","Mitotic G2-G2/M phases","3/29","68/2914",0.0287976259576966,0.0925790345602988,0.0608511238560295,"TP53/CDK2/PLK1",3
"R-HSA-2173789","R-HSA-2173789","TGF-beta receptor signaling activates SMADs","2/29","28/2914",0.030808703935005,0.0975983759692859,0.0641502786506827,"SMAD2/SMAD3",2
"R-HSA-5654733","R-HSA-5654733","Negative regulation of FGFR4 signaling","2/29","28/2914",0.030808703935005,0.0975983759692859,0.0641502786506827,"MAPK1/MAPK3",2
"R-HSA-141424","R-HSA-141424","Amplification of signal from the kinetochores","2/29","29/2914",0.0328891725797764,0.101956434997307,0.0670147802189429,"PLK1/PPP2R5C",2
"R-HSA-141444","R-HSA-141444","Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal","2/29","29/2914",0.0328891725797764,0.101956434997307,0.0670147802189429,"PLK1/PPP2R5C",2
"R-HSA-1912422","R-HSA-1912422","Pre-NOTCH Expression and Processing","2/29","29/2914",0.0328891725797764,0.101956434997307,0.0670147802189429,"TP53/NOTCH1",2
"R-HSA-4641262","R-HSA-4641262","Disassembly of the destruction complex and recruitment of AXIN to the membrane","2/29","30/2914",0.0350237777074806,0.106295940734591,0.0698670869247496,"CTNNB1/PPP2R5C",2
"R-HSA-5654726","R-HSA-5654726","Negative regulation of FGFR1 signaling","2/29","30/2914",0.0350237777074806,0.106295940734591,0.0698670869247496,"MAPK1/MAPK3",2
"R-HSA-6791312","R-HSA-6791312","TP53 Regulates Transcription of Cell Cycle Genes","2/29","30/2914",0.0350237777074806,0.106295940734591,0.0698670869247496,"TP53/CDK2",2
"R-HSA-422475","R-HSA-422475","Axon guidance","6/29","254/2914",0.0355061604244516,0.107011622390361,0.0703374961624735,"MAPK1/MAPK14/CSNK2A1/MAPK3/PAK1/ROCK2",6
"R-HSA-3769402","R-HSA-3769402","Deactivation of the beta-catenin transactivating complex","2/29","31/2914",0.0372113166320529,0.110614461769253,0.0727056006293174,"CTNNB1/HDAC1",2
"R-HSA-4791275","R-HSA-4791275","Signaling by WNT in cancer","2/29","31/2914",0.0372113166320529,0.110614461769253,0.0727056006293174,"CTNNB1/PPP2R5C",2
"R-HSA-375165","R-HSA-375165","NCAM signaling for neurite out-growth","2/29","32/2914",0.0394506037892494,0.114909812379424,0.0755288846830561,"MAPK1/MAPK3",2
"R-HSA-5654727","R-HSA-5654727","Negative regulation of FGFR2 signaling","2/29","32/2914",0.0394506037892494,0.114909812379424,0.0755288846830561,"MAPK1/MAPK3",2
"R-HSA-6802948","R-HSA-6802948","Signaling by high-kinase activity BRAF mutants","2/29","32/2914",0.0394506037892494,0.114909812379424,0.0755288846830561,"MAPK1/MAPK3",2
"R-HSA-168142","R-HSA-168142","Toll Like Receptor 10 (TLR10) Cascade","3/29","78/2914",0.040914514522919,0.11682170594044,0.0767855501088023,"MAPK1/MAPK14/MAPK3",3
"R-HSA-168176","R-HSA-168176","Toll Like Receptor 5 (TLR5) Cascade","3/29","78/2914",0.040914514522919,0.11682170594044,0.0767855501088023,"MAPK1/MAPK14/MAPK3",3
"R-HSA-975871","R-HSA-975871","MyD88 cascade initiated on plasma membrane","3/29","78/2914",0.040914514522919,0.11682170594044,0.0767855501088023,"MAPK1/MAPK14/MAPK3",3
"R-HSA-1852241","R-HSA-1852241","Organelle biogenesis and maintenance","3/29","80/2914",0.04360630109418,0.121851069956062,0.0800912926463563,"MAPK14/PLK1/MED1",3
"R-HSA-176408","R-HSA-176408","Regulation of APC/C activators between G1/S and early anaphase","2/29","34/2914",0.0440797649380223,0.121851069956062,0.0800912926463563,"CDK2/PLK1",2
"R-HSA-2500257","R-HSA-2500257","Resolution of Sister Chromatid Cohesion","2/29","34/2914",0.0440797649380223,0.121851069956062,0.0800912926463563,"PLK1/PPP2R5C",2
"R-HSA-3928662","R-HSA-3928662","EPHB-mediated forward signaling","2/29","34/2914",0.0440797649380223,0.121851069956062,0.0800912926463563,"PAK1/ROCK2",2
"R-HSA-5674135","R-HSA-5674135","MAP2K and MAPK activation","2/29","34/2914",0.0440797649380223,0.121851069956062,0.0800912926463563,"MAPK1/MAPK3",2
"R-HSA-5683057","R-HSA-5683057","MAPK family signaling cascades","5/29","202/2914",0.0462101278266058,0.126835412527745,0.0833674431118577,"MAPK1/DUSP10/MAPK3/PAK1/PPP2R5C",5
"R-HSA-373752","R-HSA-373752","Netrin-1 signaling","2/29","35/2914",0.0464673515942661,0.126835412527745,0.0833674431118577,"MAPK14/PAK1",2
"R-HSA-975138","R-HSA-975138","TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation","3/29","83/2914",0.0478089328692597,0.129681730407867,0.0852382947866407,"MAPK1/MAPK14/MAPK3",3
"R-HSA-9006934","R-HSA-9006934","Signaling by Receptor Tyrosine Kinases","7/29","347/2914",0.0489509389735692,0.131141012974764,0.0861974642642762,"MAPK1/STAT3/MAPK14/MAPK3/PAK1/CTNNB1/ROCK2",7
"R-HSA-168181","R-HSA-168181","Toll Like Receptor 7/8 (TLR7/8) Cascade","3/29","84/2914",0.0492534219237017,0.131141012974764,0.0861974642642762,"MAPK1/MAPK14/MAPK3",3
"R-HSA-975155","R-HSA-975155","MyD88 dependent cascade initiated on endosome","3/29","84/2914",0.0492534219237017,0.131141012974764,0.0861974642642762,"MAPK1/MAPK14/MAPK3",3
"R-HSA-212165","R-HSA-212165","Epigenetic regulation of gene expression","2/29","37/2914",0.0513829414497983,0.132934088222634,0.0873760317931938,"SIRT1/HDAC1",2
"R-HSA-5654741","R-HSA-5654741","Signaling by FGFR3","2/29","37/2914",0.0513829414497983,0.132934088222634,0.0873760317931938,"MAPK1/MAPK3",2
"R-HSA-166058","R-HSA-166058","MyD88:MAL(TIRAP) cascade initiated on plasma membrane","3/29","86/2914",0.0522072028823545,0.132934088222634,0.0873760317931938,"MAPK1/MAPK14/MAPK3",3
"R-HSA-168138","R-HSA-168138","Toll Like Receptor 9 (TLR9) Cascade","3/29","86/2914",0.0522072028823545,0.132934088222634,0.0873760317931938,"MAPK1/MAPK14/MAPK3",3
"R-HSA-168188","R-HSA-168188","Toll Like Receptor TLR6:TLR2 Cascade","3/29","86/2914",0.0522072028823545,0.132934088222634,0.0873760317931938,"MAPK1/MAPK14/MAPK3",3
"R-HSA-9006936","R-HSA-9006936","Signaling by TGF-beta family members","3/29","86/2914",0.0522072028823545,0.132934088222634,0.0873760317931938,"SMAD2/SMAD3/HDAC1",3
"R-HSA-168164","R-HSA-168164","Toll Like Receptor 3 (TLR3) Cascade","3/29","87/2914",0.0537162754951459,0.132934088222634,0.0873760317931938,"MAPK1/MAPK14/MAPK3",3
"R-HSA-168179","R-HSA-168179","Toll Like Receptor TLR1:TLR2 Cascade","3/29","87/2914",0.0537162754951459,0.132934088222634,0.0873760317931938,"MAPK1/MAPK14/MAPK3",3
"R-HSA-181438","R-HSA-181438","Toll Like Receptor 2 (TLR2) Cascade","3/29","87/2914",0.0537162754951459,0.132934088222634,0.0873760317931938,"MAPK1/MAPK14/MAPK3",3
"R-HSA-2454202","R-HSA-2454202","Fc epsilon receptor (FCERI) signaling","3/29","87/2914",0.0537162754951459,0.132934088222634,0.0873760317931938,"MAPK1/MAPK3/PAK1",3
"R-HSA-1592230","R-HSA-1592230","Mitochondrial biogenesis","2/29","38/2914",0.0539087546709299,0.132934088222634,0.0873760317931938,"MAPK14/MED1",2
"R-HSA-373755","R-HSA-373755","Semaphorin interactions","2/29","38/2914",0.0539087546709299,0.132934088222634,0.0873760317931938,"PAK1/ROCK2",2
"R-HSA-5654743","R-HSA-5654743","Signaling by FGFR4","2/29","38/2914",0.0539087546709299,0.132934088222634,0.0873760317931938,"MAPK1/MAPK3",2
"R-HSA-166166","R-HSA-166166","MyD88-independent TLR4 cascade ","3/29","90/2914",0.0583708249340524,0.141687958738027,0.0931298491826468,"MAPK1/MAPK14/MAPK3",3
"R-HSA-937061","R-HSA-937061","TRIF(TICAM1)-mediated TLR4 signaling ","3/29","90/2914",0.0583708249340524,0.141687958738027,0.0931298491826468,"MAPK1/MAPK14/MAPK3",3
"R-HSA-174143","R-HSA-174143","APC/C-mediated degradation of cell cycle proteins","2/29","40/2914",0.0590910611326794,0.141687958738027,0.0931298491826468,"CDK2/PLK1",2
"R-HSA-453276","R-HSA-453276","Regulation of mitotic cell cycle","2/29","40/2914",0.0590910611326794,0.141687958738027,0.0931298491826468,"CDK2/PLK1",2
"R-HSA-9013694","R-HSA-9013694","Signaling by NOTCH4","2/29","40/2914",0.0590910611326794,0.141687958738027,0.0931298491826468,"SMAD3/NOTCH1",2
"R-HSA-6811558","R-HSA-6811558","PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling","3/29","92/2914",0.0615787301678532,0.146434584180299,0.0962497509407254,"MAPK1/MAPK3/PPP2R5C",3
"R-HSA-5654736","R-HSA-5654736","Signaling by FGFR1","2/29","41/2914",0.0617454583064395,0.146434584180299,0.0962497509407254,"MAPK1/MAPK3",2
"R-HSA-418346","R-HSA-418346","Platelet homeostasis","2/29","42/2914",0.0644406461642308,0.147974817117863,0.0972621281565388,"MAPK14/PPP2R5C",2
"R-HSA-6802946","R-HSA-6802946","Signaling by moderate kinase activity BRAF mutants","2/29","42/2914",0.0644406461642308,0.147974817117863,0.0972621281565388,"MAPK1/MAPK3",2
"R-HSA-6802949","R-HSA-6802949","Signaling by RAS mutants","2/29","42/2914",0.0644406461642308,0.147974817117863,0.0972621281565388,"MAPK1/MAPK3",2
"R-HSA-6802955","R-HSA-6802955","Paradoxical activation of RAF signaling by kinase inactive BRAF","2/29","42/2914",0.0644406461642308,0.147974817117863,0.0972621281565388,"MAPK1/MAPK3",2
"R-HSA-69618","R-HSA-69618","Mitotic Spindle Checkpoint","2/29","42/2914",0.0644406461642308,0.147974817117863,0.0972621281565388,"PLK1/PPP2R5C",2
"R-HSA-9649948","R-HSA-9649948","Signaling downstream of RAS mutants","2/29","42/2914",0.0644406461642308,0.147974817117863,0.0972621281565388,"MAPK1/MAPK3",2
"R-HSA-199418","R-HSA-199418","Negative regulation of the PI3K/AKT network","3/29","99/2914",0.073450133815972,0.167775568821747,0.110276932211238,"MAPK1/MAPK3/PPP2R5C",3
"R-HSA-6802952","R-HSA-6802952","Signaling by BRAF and RAF fusions","2/29","46/2914",0.0756093225555315,0.171803382141888,0.112924367112422,"MAPK1/MAPK3",2
"R-HSA-438064","R-HSA-438064","Post NMDA receptor activation events","2/29","47/2914",0.0784936052626454,0.176508936186467,0.116017273117954,"MAPK1/MAPK3",2
"R-HSA-5663220","R-HSA-5663220","RHO GTPases Activate Formins","2/29","47/2914",0.0784936052626454,0.176508936186467,0.116017273117954,"PLK1/PPP2R5C",2
"R-HSA-442755","R-HSA-442755","Activation of NMDA receptors and postsynaptic events","2/29","49/2914",0.084366092447731,0.187768636524694,0.123418143337841,"MAPK1/MAPK3",2
"R-HSA-6802957","R-HSA-6802957","Oncogenic MAPK signaling","2/29","49/2914",0.084366092447731,0.187768636524694,0.123418143337841,"MAPK1/MAPK3",2
"R-HSA-5673001","R-HSA-5673001","RAF/MAP kinase cascade","4/29","171/2914",0.0864819731881488,0.191495797773758,0.125867963125609,"MAPK1/DUSP10/MAPK3/PPP2R5C",4
"R-HSA-5654738","R-HSA-5654738","Signaling by FGFR2","2/29","50/2914",0.0873524629888162,0.192441466686021,0.126489540315091,"MAPK1/MAPK3",2
"R-HSA-195721","R-HSA-195721","Signaling by WNT","4/29","172/2914",0.087939486072544,0.19275624724992,0.126696441922698,"CSNK2A1/CTNNB1/PPP2R5C/HDAC1",4
"R-HSA-2644602","R-HSA-2644602","Signaling by NOTCH1 PEST Domain Mutants in Cancer","2/29","51/2914",0.0903710516706435,0.193207075985514,0.126992766412986,"NOTCH1/HDAC1",2
"R-HSA-2644603","R-HSA-2644603","Signaling by NOTCH1 in Cancer","2/29","51/2914",0.0903710516706435,0.193207075985514,0.126992766412986,"NOTCH1/HDAC1",2
"R-HSA-2644606","R-HSA-2644606","Constitutive Signaling by NOTCH1 PEST Domain Mutants","2/29","51/2914",0.0903710516706435,0.193207075985514,0.126992766412986,"NOTCH1/HDAC1",2
"R-HSA-2894858","R-HSA-2894858","Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer","2/29","51/2914",0.0903710516706435,0.193207075985514,0.126992766412986,"NOTCH1/HDAC1",2
"R-HSA-2894862","R-HSA-2894862","Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants","2/29","51/2914",0.0903710516706435,0.193207075985514,0.126992766412986,"NOTCH1/HDAC1",2
"R-HSA-74751","R-HSA-74751","Insulin receptor signalling cascade","2/29","52/2914",0.0934209754749383,0.193497495860315,0.127183656022666,"MAPK1/MAPK3",2
"R-HSA-74752","R-HSA-74752","Signaling by Insulin receptor","2/29","52/2914",0.0934209754749383,0.193497495860315,0.127183656022666,"MAPK1/MAPK3",2
"R-HSA-166016","R-HSA-166016","Toll Like Receptor 4 (TLR4) Cascade","3/29","110/2914",0.0940286506210337,0.193497495860315,0.127183656022666,"MAPK1/MAPK14/MAPK3",3
"R-HSA-110056","R-HSA-110056","MAPK3 (ERK1) activation","1/29","10/2914",0.0953196913992334,0.193497495860315,0.127183656022666,"MAPK3",1
"R-HSA-1362300","R-HSA-1362300","Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1","1/29","10/2914",0.0953196913992334,0.193497495860315,0.127183656022666,"HDAC1",1
"R-HSA-6804759","R-HSA-6804759","Regulation of TP53 Activity through Association with Co-factors","1/29","10/2914",0.0953196913992334,0.193497495860315,0.127183656022666,"TP53",1
"R-HSA-8934903","R-HSA-8934903","Receptor Mediated Mitophagy","1/29","10/2914",0.0953196913992334,0.193497495860315,0.127183656022666,"CSNK2A1",1
"R-HSA-9020956","R-HSA-9020956","Interleukin-27 signaling","1/29","10/2914",0.0953196913992334,0.193497495860315,0.127183656022666,"STAT3",1
"R-HSA-9020958","R-HSA-9020958","Interleukin-21 signaling","1/29","10/2914",0.0953196913992334,0.193497495860315,0.127183656022666,"STAT3",1
"R-HSA-9617629","R-HSA-9617629","Regulation of FOXO transcriptional activity by acetylation","1/29","10/2914",0.0953196913992334,0.193497495860315,0.127183656022666,"SIRT1",1
"R-HSA-5684996","R-HSA-5684996","MAPK1/MAPK3 signaling","4/29","177/2914",0.0954112076361922,0.193497495860315,0.127183656022666,"MAPK1/DUSP10/MAPK3/PPP2R5C",4
"R-HSA-388841","R-HSA-388841","Costimulation by the CD28 family","2/29","53/2914",0.0965013646668452,0.19479810356005,0.128038530353562,"PAK1/PPP2R5C",2
"R-HSA-190236","R-HSA-190236","Signaling by FGFR","2/29","55/2914",0.10275012572062,0.201287335389338,0.132303827044653,"MAPK1/MAPK3",2
"R-HSA-1059683","R-HSA-1059683","Interleukin-6 signaling","1/29","11/2914",0.104354033323965,0.201287335389338,0.132303827044653,"STAT3",1
"R-HSA-1362277","R-HSA-1362277","Transcription of E2F targets under negative control by DREAM complex","1/29","11/2914",0.104354033323965,0.201287335389338,0.132303827044653,"HDAC1",1
"R-HSA-2586552","R-HSA-2586552","Signaling by Leptin","1/29","11/2914",0.104354033323965,0.201287335389338,0.132303827044653,"STAT3",1
"R-HSA-349425","R-HSA-349425","Autodegradation of the E3 ubiquitin ligase COP1","1/29","11/2914",0.104354033323965,0.201287335389338,0.132303827044653,"TP53",1
"R-HSA-380994","R-HSA-380994","ATF4 activates genes in response to endoplasmic reticulum  stress","1/29","11/2914",0.104354033323965,0.201287335389338,0.132303827044653,"CEBPB",1
"R-HSA-416572","R-HSA-416572","Sema4D induced cell migration and growth-cone collapse","1/29","11/2914",0.104354033323965,0.201287335389338,0.132303827044653,"ROCK2",1
"R-HSA-6803207","R-HSA-6803207","TP53 Regulates Transcription of Caspase Activators and Caspases","1/29","11/2914",0.104354033323965,0.201287335389338,0.132303827044653,"TP53",1
"R-HSA-8866910","R-HSA-8866910","TFAP2 (AP-2) family regulates transcription of growth factors and their receptors","1/29","11/2914",0.104354033323965,0.201287335389338,0.132303827044653,"YY1",1
"R-HSA-8984722","R-HSA-8984722","Interleukin-35 Signalling","1/29","11/2914",0.104354033323965,0.201287335389338,0.132303827044653,"STAT3",1
"R-HSA-2467813","R-HSA-2467813","Separation of Sister Chromatids","2/29","56/2914",0.105916823080139,0.203397792994602,0.133691006309816,"PLK1/PPP2R5C",2
"R-HSA-9607240","R-HSA-9607240","FLT3 Signaling","4/29","188/2914",0.112900475573939,0.204704082819141,0.134549615435331,"MAPK1/DUSP10/MAPK3/PPP2R5C",4
"R-HSA-1483206","R-HSA-1483206","Glycerophospholipid biosynthesis","1/29","12/2914",0.113301237262513,0.204704082819141,0.134549615435331,"CSNK2A1",1
"R-HSA-1839117","R-HSA-1839117","Signaling by cytosolic FGFR1 fusion mutants","1/29","12/2914",0.113301237262513,0.204704082819141,0.134549615435331,"STAT3",1
"R-HSA-210744","R-HSA-210744","Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells","1/29","12/2914",0.113301237262513,0.204704082819141,0.134549615435331,"NOTCH1",1
"R-HSA-2691230","R-HSA-2691230","Signaling by NOTCH1 HD Domain Mutants in Cancer","1/29","12/2914",0.113301237262513,0.204704082819141,0.134549615435331,"NOTCH1",1
"R-HSA-2691232","R-HSA-2691232","Constitutive Signaling by NOTCH1 HD Domain Mutants","1/29","12/2914",0.113301237262513,0.204704082819141,0.134549615435331,"NOTCH1",1
"R-HSA-381771","R-HSA-381771","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","1/29","12/2914",0.113301237262513,0.204704082819141,0.134549615435331,"CTNNB1",1
"R-HSA-389359","R-HSA-389359","CD28 dependent Vav1 pathway","1/29","12/2914",0.113301237262513,0.204704082819141,0.134549615435331,"PAK1",1
"R-HSA-399954","R-HSA-399954","Sema3A PAK dependent Axon repulsion","1/29","12/2914",0.113301237262513,0.204704082819141,0.134549615435331,"PAK1",1
"R-HSA-418990","R-HSA-418990","Adherens junctions interactions","1/29","12/2914",0.113301237262513,0.204704082819141,0.134549615435331,"CTNNB1",1
"R-HSA-68962","R-HSA-68962","Activation of the pre-replicative complex","1/29","12/2914",0.113301237262513,0.204704082819141,0.134549615435331,"CDK2",1
"R-HSA-9005891","R-HSA-9005891","Loss of function of MECP2 in Rett syndrome","1/29","12/2914",0.113301237262513,0.204704082819141,0.134549615435331,"HDAC1",1
"R-HSA-9005895","R-HSA-9005895","Pervasive developmental disorders","1/29","12/2914",0.113301237262513,0.204704082819141,0.134549615435331,"HDAC1",1
"R-HSA-9022699","R-HSA-9022699","MECP2 regulates neuronal receptors and channels","1/29","12/2914",0.113301237262513,0.204704082819141,0.134549615435331,"HDAC1",1
"R-HSA-68882","R-HSA-68882","Mitotic Anaphase","2/29","60/2914",0.118846777587426,0.204704082819141,0.134549615435331,"PLK1/PPP2R5C",2
"R-HSA-69206","R-HSA-69206","G1/S Transition","2/29","60/2914",0.118846777587426,0.204704082819141,0.134549615435331,"CDK2/HDAC1",2
"R-HSA-2555396","R-HSA-2555396","Mitotic Metaphase and Anaphase","2/29","61/2914",0.122141120757945,0.204704082819141,0.134549615435331,"PLK1/PPP2R5C",2
"R-HSA-1368082","R-HSA-1368082","RORA activates gene expression","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"MED1",1
"R-HSA-171007","R-HSA-171007","p38MAPK events","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"MAPK14",1
"R-HSA-3906995","R-HSA-3906995","Diseases associated with O-glycosylation of proteins","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"NOTCH1",1
"R-HSA-428540","R-HSA-428540","Activation of RAC1","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"PAK1",1
"R-HSA-4839735","R-HSA-4839735","AXIN mutants destabilize the destruction complex, activating WNT signaling","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"PPP2R5C",1
"R-HSA-4839744","R-HSA-4839744","truncated APC mutants destabilize the destruction complex","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"PPP2R5C",1
"R-HSA-4839748","R-HSA-4839748","AMER1 mutants destabilize the destruction complex","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"PPP2R5C",1
"R-HSA-5467337","R-HSA-5467337","APC truncation mutants have impaired AXIN binding","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"PPP2R5C",1
"R-HSA-5467340","R-HSA-5467340","AXIN missense mutants destabilize the destruction complex","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"PPP2R5C",1
"R-HSA-5467348","R-HSA-5467348","Truncations of AMER1 destabilize the destruction complex","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"PPP2R5C",1
"R-HSA-5626467","R-HSA-5626467","RHO GTPases activate IQGAPs","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"CTNNB1",1
"R-HSA-6804760","R-HSA-6804760","Regulation of TP53 Activity through Methylation","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"TP53",1
"R-HSA-8941856","R-HSA-8941856","RUNX3 regulates NOTCH signaling","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"NOTCH1",1
"R-HSA-8964616","R-HSA-8964616","G beta:gamma signalling through CDC42","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"PAK1",1
"R-HSA-912446","R-HSA-912446","Meiotic recombination","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"CDK2",1
"R-HSA-9614657","R-HSA-9614657","FOXO-mediated transcription of cell death genes","1/29","13/2914",0.122162113940455,0.204704082819141,0.134549615435331,"STK11",1
"R-HSA-69481","R-HSA-69481","G2/M Checkpoints","2/29","62/2914",0.125458673286237,0.209419477716256,0.137648989718907,"TP53/CDK2",2
"R-HSA-9009391","R-HSA-9009391","Extra-nuclear estrogen signaling","2/29","63/2914",0.128798689641342,0.212834683890293,0.139893765060076,"MAPK1/MAPK3",2
"R-HSA-168898","R-HSA-168898","Toll-like Receptor Cascades","3/29","127/2914",0.129980855858874,0.212834683890293,0.139893765060076,"MAPK1/MAPK14/MAPK3",3
"R-HSA-2426168","R-HSA-2426168","Activation of gene expression by SREBF (SREBP)","1/29","14/2914",0.1309374668173,0.212834683890293,0.139893765060076,"MED1",1
"R-HSA-381042","R-HSA-381042","PERK regulates gene expression","1/29","14/2914",0.1309374668173,0.212834683890293,0.139893765060076,"CEBPB",1
"R-HSA-400508","R-HSA-400508","Incretin synthesis, secretion, and inactivation","1/29","14/2914",0.1309374668173,0.212834683890293,0.139893765060076,"CTNNB1",1
"R-HSA-445355","R-HSA-445355","Smooth Muscle Contraction","1/29","14/2914",0.1309374668173,0.212834683890293,0.139893765060076,"PAK1",1
"R-HSA-8983432","R-HSA-8983432","Interleukin-15 signaling","1/29","14/2914",0.1309374668173,0.212834683890293,0.139893765060076,"STAT3",1
"R-HSA-176412","R-HSA-176412","Phosphorylation of the APC/C","1/29","15/2914",0.139628092149127,0.219560115915656,0.144314313395932,"PLK1",1
"R-HSA-400685","R-HSA-400685","Sema4D in semaphorin signaling","1/29","15/2914",0.139628092149127,0.219560115915656,0.144314313395932,"ROCK2",1
"R-HSA-427413","R-HSA-427413","NoRC negatively regulates rRNA expression","1/29","15/2914",0.139628092149127,0.219560115915656,0.144314313395932,"HDAC1",1
"R-HSA-5250913","R-HSA-5250913","Positive epigenetic regulation of rRNA expression","1/29","15/2914",0.139628092149127,0.219560115915656,0.144314313395932,"HDAC1",1
"R-HSA-6803204","R-HSA-6803204","TP53 Regulates Transcription of Genes Involved in Cytochrome C Release","1/29","15/2914",0.139628092149127,0.219560115915656,0.144314313395932,"TP53",1
"R-HSA-6804114","R-HSA-6804114","TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest","1/29","15/2914",0.139628092149127,0.219560115915656,0.144314313395932,"TP53",1
"R-HSA-69205","R-HSA-69205","G1/S-Specific Transcription","1/29","15/2914",0.139628092149127,0.219560115915656,0.144314313395932,"HDAC1",1
"R-HSA-69541","R-HSA-69541","Stabilization of p53","1/29","15/2914",0.139628092149127,0.219560115915656,0.144314313395932,"TP53",1
"R-HSA-8876384","R-HSA-8876384","Listeria monocytogenes entry into host cells","1/29","15/2914",0.139628092149127,0.219560115915656,0.144314313395932,"CTNNB1",1
"R-HSA-2682334","R-HSA-2682334","EPH-Ephrin signaling","2/29","68/2914",0.145810438815508,0.22732824773147,0.149420216190222,"PAK1/ROCK2",2
"R-HSA-176187","R-HSA-176187","Activation of ATR in response to replication stress","1/29","16/2914",0.148234779050705,0.22732824773147,0.149420216190222,"CDK2",1
"R-HSA-3214815","R-HSA-3214815","HDACs deacetylate histones","1/29","16/2914",0.148234779050705,0.22732824773147,0.149420216190222,"HDAC1",1
"R-HSA-3232118","R-HSA-3232118","SUMOylation of transcription factors","1/29","16/2914",0.148234779050705,0.22732824773147,0.149420216190222,"TP53",1
"R-HSA-3928664","R-HSA-3928664","Ephrin signaling","1/29","16/2914",0.148234779050705,0.22732824773147,0.149420216190222,"PAK1",1
"R-HSA-5205647","R-HSA-5205647","Mitophagy","1/29","16/2914",0.148234779050705,0.22732824773147,0.149420216190222,"CSNK2A1",1
"R-HSA-5627123","R-HSA-5627123","RHO GTPases activate PAKs","1/29","16/2914",0.148234779050705,0.22732824773147,0.149420216190222,"PAK1",1
"R-HSA-418592","R-HSA-418592","ADP signalling through P2Y purinoceptor 1","1/29","17/2914",0.156758309557099,0.23787799422301,0.156354441994751,"MAPK14",1
"R-HSA-5696394","R-HSA-5696394","DNA Damage Recognition in GG-NER","1/29","17/2914",0.156758309557099,0.23787799422301,0.156354441994751,"YY1",1
"R-HSA-68949","R-HSA-68949","Orc1 removal from chromatin","1/29","17/2914",0.156758309557099,0.23787799422301,0.156354441994751,"CDK2",1
"R-HSA-1234176","R-HSA-1234176","Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha","1/29","18/2914",0.165199458684764,0.246379948691366,0.161942677893185,"HIF1A",1
"R-HSA-202433","R-HSA-202433","Generation of second messenger molecules","1/29","18/2914",0.165199458684764,0.246379948691366,0.161942677893185,"PAK1",1
"R-HSA-380972","R-HSA-380972","Energy dependent regulation of mTOR by LKB1-AMPK","1/29","18/2914",0.165199458684764,0.246379948691366,0.161942677893185,"STK11",1
"R-HSA-8939243","R-HSA-8939243","RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known","1/29","18/2914",0.165199458684764,0.246379948691366,0.161942677893185,"CSNK2A1",1
"R-HSA-9013508","R-HSA-9013508","NOTCH3 Intracellular Domain Regulates Transcription","1/29","18/2914",0.165199458684764,0.246379948691366,0.161942677893185,"NOTCH1",1
"R-HSA-1368108","R-HSA-1368108","BMAL1:CLOCK,NPAS2 activates circadian gene expression","1/29","19/2914",0.173558994492133,0.252767126206663,0.166140895469332,"MED1",1
"R-HSA-2980766","R-HSA-2980766","Nuclear Envelope Breakdown","1/29","19/2914",0.173558994492133,0.252767126206663,0.166140895469332,"PLK1",1
"R-HSA-389513","R-HSA-389513","CTLA4 inhibitory signaling","1/29","19/2914",0.173558994492133,0.252767126206663,0.166140895469332,"PPP2R5C",1
"R-HSA-421270","R-HSA-421270","Cell-cell junction organization","1/29","19/2914",0.173558994492133,0.252767126206663,0.166140895469332,"CTNNB1",1
"R-HSA-5621575","R-HSA-5621575","CD209 (DC-SIGN) signaling","1/29","19/2914",0.173558994492133,0.252767126206663,0.166140895469332,"PAK1",1
"R-HSA-6814122","R-HSA-6814122","Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding","1/29","19/2914",0.173558994492133,0.252767126206663,0.166140895469332,"CSNK2A1",1
"R-HSA-73762","R-HSA-73762","RNA Polymerase I Transcription Initiation","1/29","19/2914",0.173558994492133,0.252767126206663,0.166140895469332,"HDAC1",1
"R-HSA-112314","R-HSA-112314","Neurotransmitter receptors and postsynaptic signal transmission","2/29","77/2914",0.177526846510743,0.256822171285542,0.168806229489163,"MAPK1/MAPK3",2
"R-HSA-453279","R-HSA-453279","Mitotic G1-G1/S phases","2/29","77/2914",0.177526846510743,0.256822171285542,0.168806229489163,"CDK2/HDAC1",2
"R-HSA-1655829","R-HSA-1655829","Regulation of cholesterol biosynthesis by SREBP (SREBF)","1/29","20/2914",0.181837678139708,0.259597211554714,0.170630231218355,"MED1",1
"R-HSA-167044","R-HSA-167044","Signalling to RAS","1/29","20/2914",0.181837678139708,0.259597211554714,0.170630231218355,"MAPK14",1
"R-HSA-437239","R-HSA-437239","Recycling pathway of L1","1/29","20/2914",0.181837678139708,0.259597211554714,0.170630231218355,"MAPK1",1
"R-HSA-8936459","R-HSA-8936459","RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function","1/29","20/2914",0.181837678139708,0.259597211554714,0.170630231218355,"HDAC1",1
"R-HSA-597592","R-HSA-597592","Post-translational protein modification","6/29","393/2914",0.187445654007373,0.266050769529498,0.17487207989933,"TP53/HIF1A/SMAD2/SMAD3/YY1/HDAC1",6
"R-HSA-111465","R-HSA-111465","Apoptotic cleavage of cellular proteins","1/29","21/2914",0.190036263949641,0.266050769529498,0.17487207989933,"CTNNB1",1
"R-HSA-3781865","R-HSA-3781865","Diseases of glycosylation","1/29","21/2914",0.190036263949641,0.266050769529498,0.17487207989933,"NOTCH1",1
"R-HSA-3928663","R-HSA-3928663","EPHA-mediated growth cone collapse","1/29","21/2914",0.190036263949641,0.266050769529498,0.17487207989933,"ROCK2",1
"R-HSA-397795","R-HSA-397795","G-protein beta:gamma signalling","1/29","21/2914",0.190036263949641,0.266050769529498,0.17487207989933,"PAK1",1
"R-HSA-450302","R-HSA-450302","activated TAK1 mediates p38 MAPK activation","1/29","21/2914",0.190036263949641,0.266050769529498,0.17487207989933,"MAPK14",1
"R-HSA-5693532","R-HSA-5693532","DNA Double-Strand Break Repair","2/29","81/2914",0.191976941519321,0.267903513245611,0.176089866819211,"TP53/CDK2",2
"R-HSA-76002","R-HSA-76002","Platelet activation, signaling and aggregation","3/29","153/2914",0.192798100729013,0.268187101655101,0.176276266186108,"MAPK1/MAPK14/MAPK3",3
"R-HSA-446652","R-HSA-446652","Interleukin-1 family signaling","2/29","82/2914",0.195616710452103,0.271238505866494,0.178281918723793,"STAT3/SMAD3",2
"R-HSA-1266695","R-HSA-1266695","Interleukin-7 signaling","1/29","22/2914",0.198155499464837,0.271291756365108,0.178316919657881,"STAT3",1
"R-HSA-1500620","R-HSA-1500620","Meiosis","1/29","22/2914",0.198155499464837,0.271291756365108,0.178316919657881,"CDK2",1
"R-HSA-187577","R-HSA-187577","SCF(Skp2)-mediated degradation of p27/p21","1/29","22/2914",0.198155499464837,0.271291756365108,0.178316919657881,"CDK2",1
"R-HSA-9022692","R-HSA-9022692","Regulation of MECP2 expression and activity","1/29","22/2914",0.198155499464837,0.271291756365108,0.178316919657881,"HDAC1",1
"R-HSA-73894","R-HSA-73894","DNA Repair","3/29","157/2914",0.203117357085152,0.277210481053321,0.182207228633156,"TP53/CDK2/YY1",3
"R-HSA-392518","R-HSA-392518","Signal amplification","1/29","23/2914",0.206196125507548,0.277916516988434,0.182671297850753,"MAPK14",1
"R-HSA-4551638","R-HSA-4551638","SUMOylation of chromatin organization proteins","1/29","23/2914",0.206196125507548,0.277916516988434,0.182671297850753,"HDAC1",1
"R-HSA-6783589","R-HSA-6783589","Interleukin-6 family signaling","1/29","23/2914",0.206196125507548,0.277916516988434,0.182671297850753,"STAT3",1
"R-HSA-69002","R-HSA-69002","DNA Replication Pre-Initiation","1/29","23/2914",0.206196125507548,0.277916516988434,0.182671297850753,"CDK2",1
"R-HSA-8878171","R-HSA-8878171","Transcriptional regulation by RUNX1","2/29","86/2914",0.210268586177696,0.282507453760102,0.185688867254396,"CSNK2A1/HDAC1",2
"R-HSA-1234174","R-HSA-1234174","Cellular response to hypoxia","1/29","24/2914",0.214158876237496,0.282507453760102,0.185688867254396,"HIF1A",1
"R-HSA-1474165","R-HSA-1474165","Reproduction","1/29","24/2914",0.214158876237496,0.282507453760102,0.185688867254396,"CDK2",1
"R-HSA-1839124","R-HSA-1839124","FGFR1 mutant receptor activation","1/29","24/2914",0.214158876237496,0.282507453760102,0.185688867254396,"STAT3",1
"R-HSA-186712","R-HSA-186712","Regulation of beta-cell development","1/29","24/2914",0.214158876237496,0.282507453760102,0.185688867254396,"NOTCH1",1
"R-HSA-5625740","R-HSA-5625740","RHO GTPases activate PKNs","1/29","24/2914",0.214158876237496,0.282507453760102,0.185688867254396,"PAK1",1
"R-HSA-8854691","R-HSA-8854691","Interleukin-20 family signaling","1/29","24/2914",0.214158876237496,0.282507453760102,0.185688867254396,"STAT3",1
"R-HSA-112315","R-HSA-112315","Transmission across Chemical Synapses","2/29","88/2914",0.217642996000508,0.286233515952184,0.188137964644778,"MAPK1/MAPK3",2
"R-HSA-380259","R-HSA-380259","Loss of Nlp from mitotic centrosomes","1/29","25/2914",0.222044479209508,0.288524862206366,0.189644039917354,"PLK1",1
"R-HSA-380284","R-HSA-380284","Loss of proteins required for interphase microtubule organization from the centrosome","1/29","25/2914",0.222044479209508,0.288524862206366,0.189644039917354,"PLK1",1
"R-HSA-8864260","R-HSA-8864260","Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors","1/29","25/2914",0.222044479209508,0.288524862206366,0.189644039917354,"YY1",1
"R-HSA-8948751","R-HSA-8948751","Regulation of PTEN stability and activity","1/29","25/2914",0.222044479209508,0.288524862206366,0.189644039917354,"CSNK2A1",1
"R-HSA-111996","R-HSA-111996","Ca-dependent events","1/29","26/2914",0.229853655430665,0.294266921701795,0.193418228913865,"MAPK1",1
"R-HSA-380320","R-HSA-380320","Recruitment of NuMA to mitotic centrosomes","1/29","26/2914",0.229853655430665,0.294266921701795,0.193418228913865,"PLK1",1
"R-HSA-75153","R-HSA-75153","Apoptotic execution phase","1/29","26/2914",0.229853655430665,0.294266921701795,0.193418228913865,"CTNNB1",1
"R-HSA-8854518","R-HSA-8854518","AURKA Activation by TPX2","1/29","26/2914",0.229853655430665,0.294266921701795,0.193418228913865,"PLK1",1
"R-HSA-8939902","R-HSA-8939902","Regulation of RUNX2 expression and activity","1/29","26/2914",0.229853655430665,0.294266921701795,0.193418228913865,"TWIST1",1
"R-HSA-165159","R-HSA-165159","mTOR signalling","1/29","27/2914",0.237587119416991,0.296301177663719,0.194755321724152,"STK11",1
"R-HSA-2122948","R-HSA-2122948","Activated NOTCH1 Transmits Signal to the Nucleus","1/29","27/2914",0.237587119416991,0.296301177663719,0.194755321724152,"NOTCH1",1
"R-HSA-380270","R-HSA-380270","Recruitment of mitotic centrosome proteins and complexes","1/29","27/2914",0.237587119416991,0.296301177663719,0.194755321724152,"PLK1",1
"R-HSA-380287","R-HSA-380287","Centrosome maturation","1/29","27/2914",0.237587119416991,0.296301177663719,0.194755321724152,"PLK1",1
"R-HSA-5617472","R-HSA-5617472","Activation of anterior HOX genes in hindbrain development during early embryogenesis","1/29","27/2914",0.237587119416991,0.296301177663719,0.194755321724152,"YY1",1
"R-HSA-5619507","R-HSA-5619507","Activation of HOX genes during differentiation","1/29","27/2914",0.237587119416991,0.296301177663719,0.194755321724152,"YY1",1
"R-HSA-5689603","R-HSA-5689603","UCH proteinases","1/29","27/2914",0.237587119416991,0.296301177663719,0.194755321724152,"YY1",1
"R-HSA-5689896","R-HSA-5689896","Ovarian tumor domain proteases","1/29","27/2914",0.237587119416991,0.296301177663719,0.194755321724152,"TP53",1
"R-HSA-69017","R-HSA-69017","CDK-mediated phosphorylation and removal of Cdc6","1/29","27/2914",0.237587119416991,0.296301177663719,0.194755321724152,"CDK2",1
"R-HSA-174178","R-HSA-174178","APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1","1/29","28/2914",0.245245579249658,0.303238123630631,0.199314895716471,"PLK1",1
"R-HSA-5620912","R-HSA-5620912","Anchoring of the basal body to the plasma membrane","1/29","28/2914",0.245245579249658,0.303238123630631,0.199314895716471,"PLK1",1
"R-HSA-8957322","R-HSA-8957322","Metabolism of steroids","1/29","28/2914",0.245245579249658,0.303238123630631,0.199314895716471,"MED1",1
"R-HSA-913531","R-HSA-913531","Interferon Signaling","2/29","97/2914",0.251108682208019,0.308225016004873,0.202592722137571,"MAPK3/CIITA",2
"R-HSA-114452","R-HSA-114452","Activation of BH3-only proteins","1/29","29/2914",0.252829736630725,0.308225016004873,0.202592722137571,"TP53",1
"R-HSA-186763","R-HSA-186763","Downstream signal transduction","1/29","29/2914",0.252829736630725,0.308225016004873,0.202592722137571,"STAT3",1
"R-HSA-381119","R-HSA-381119","Unfolded Protein Response (UPR)","1/29","29/2914",0.252829736630725,0.308225016004873,0.202592722137571,"CEBPB",1
"R-HSA-5673000","R-HSA-5673000","RAF activation","1/29","29/2914",0.252829736630725,0.308225016004873,0.202592722137571,"PPP2R5C",1
"R-HSA-1483257","R-HSA-1483257","Phospholipid metabolism","1/29","30/2914",0.260340286938423,0.314728926270963,0.206867666794642,"CSNK2A1",1
"R-HSA-176814","R-HSA-176814","Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins","1/29","30/2914",0.260340286938423,0.314728926270963,0.206867666794642,"PLK1",1
"R-HSA-5633008","R-HSA-5633008","TP53 Regulates Transcription of Cell Death Genes","1/29","30/2914",0.260340286938423,0.314728926270963,0.206867666794642,"TP53",1
"R-HSA-389356","R-HSA-389356","CD28 co-stimulation","1/29","31/2914",0.267777919281968,0.321037615934735,0.211014295217835,"PAK1",1
"R-HSA-450531","R-HSA-450531","Regulation of mRNA stability by proteins that bind AU-rich elements","1/29","31/2914",0.267777919281968,0.321037615934735,0.211014295217835,"MAPK14",1
"R-HSA-5655302","R-HSA-5655302","Signaling by FGFR1 in disease","1/29","31/2914",0.267777919281968,0.321037615934735,0.211014295217835,"STAT3",1
"R-HSA-2151201","R-HSA-2151201","Transcriptional activation of mitochondrial biogenesis","1/29","32/2914",0.275143316555927,0.328055492816682,0.215627064160371,"MED1",1
"R-HSA-447115","R-HSA-447115","Interleukin-12 family signaling","1/29","32/2914",0.275143316555927,0.328055492816682,0.215627064160371,"STAT3",1
"R-HSA-112316","R-HSA-112316","Neuronal System","2/29","105/2914",0.28105429324724,0.333999252001224,0.219533828019238,"MAPK1/MAPK3",2
"R-HSA-168638","R-HSA-168638","NOD1/2 Signaling Pathway","1/29","33/2914",0.282437155494123,0.333999252001224,0.219533828019238,"MAPK14",1
"R-HSA-69052","R-HSA-69052","Switching of origins to a post-replicative state","1/29","33/2914",0.282437155494123,0.333999252001224,0.219533828019238,"CDK2",1
"R-HSA-3108232","R-HSA-3108232","SUMO E3 ligases SUMOylate target proteins","2/29","107/2914",0.288544769417746,0.335233296847529,0.220344951359884,"TP53/HDAC1",2
"R-HSA-112040","R-HSA-112040","G-protein mediated events","1/29","34/2914",0.289660106723095,0.335233296847529,0.220344951359884,"MAPK1",1
"R-HSA-112043","R-HSA-112043","PLC beta mediated events","1/29","34/2914",0.289660106723095,0.335233296847529,0.220344951359884,"MAPK1",1
"R-HSA-1169408","R-HSA-1169408","ISG15 antiviral mechanism","1/29","34/2914",0.289660106723095,0.335233296847529,0.220344951359884,"MAPK3",1
"R-HSA-1834949","R-HSA-1834949","Cytosolic sensors of pathogen-associated DNA ","1/29","34/2914",0.289660106723095,0.335233296847529,0.220344951359884,"CTNNB1",1
"R-HSA-5687128","R-HSA-5687128","MAPK6/MAPK4 signaling","1/29","34/2914",0.289660106723095,0.335233296847529,0.220344951359884,"PAK1",1
"R-HSA-5693565","R-HSA-5693565","Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks","1/29","34/2914",0.289660106723095,0.335233296847529,0.220344951359884,"TP53",1
"R-HSA-6796648","R-HSA-6796648","TP53 Regulates Transcription of DNA Repair Genes","1/29","34/2914",0.289660106723095,0.335233296847529,0.220344951359884,"TP53",1
"R-HSA-2990846","R-HSA-2990846","SUMOylation","2/29","109/2914",0.296031123819727,0.338991500815163,0.222815175165921,"TP53/HDAC1",2
"R-HSA-1169410","R-HSA-1169410","Antiviral mechanism by IFN-stimulated genes","1/29","35/2914",0.296812834815119,0.338991500815163,0.222815175165921,"MAPK3",1
"R-HSA-446728","R-HSA-446728","Cell junction organization","1/29","35/2914",0.296812834815119,0.338991500815163,0.222815175165921,"CTNNB1",1
"R-HSA-5628897","R-HSA-5628897","TP53 Regulates Metabolic Genes","1/29","35/2914",0.296812834815119,0.338991500815163,0.222815175165921,"TP53",1
"R-HSA-5693606","R-HSA-5693606","DNA Double Strand Break Response","1/29","35/2914",0.296812834815119,0.338991500815163,0.222815175165921,"TP53",1
"R-HSA-2565942","R-HSA-2565942","Regulation of PLK1 Activity at G2/M Transition","1/29","37/2914",0.310910249921079,0.353233111166881,0.232176020194578,"PLK1",1
"R-HSA-9012852","R-HSA-9012852","Signaling by NOTCH3","1/29","37/2914",0.310910249921079,0.353233111166881,0.232176020194578,"NOTCH1",1
"R-HSA-69202","R-HSA-69202","Cyclin E associated events during G1/S transition ","1/29","39/2914",0.324734598291676,0.367976019996311,0.241866362888674,"CDK2",1
"R-HSA-4086398","R-HSA-4086398","Ca2+ pathway","1/29","40/2914",0.331545971039342,0.373742730989804,0.245656755028467,"CTNNB1",1
"R-HSA-69656","R-HSA-69656","Cyclin A:Cdk2-associated events at S phase entry","1/29","40/2914",0.331545971039342,0.373742730989804,0.245656755028467,"CDK2",1
"R-HSA-556833","R-HSA-556833","Metabolism of lipids","2/29","119/2914",0.33331034720049,0.374758266023349,0.246324254407779,"CSNK2A1/MED1",2
"R-HSA-1433557","R-HSA-1433557","Signaling by SCF-KIT","1/29","41/2914",0.338290983857665,0.377424902298783,0.248077003451298,"STAT3",1
"R-HSA-451927","R-HSA-451927","Interleukin-2 family signaling","1/29","41/2914",0.338290983857665,0.377424902298783,0.248077003451298,"STAT3",1
"R-HSA-8986944","R-HSA-8986944","Transcriptional Regulation by MECP2","1/29","41/2914",0.338290983857665,0.377424902298783,0.248077003451298,"HDAC1",1
"R-HSA-2980736","R-HSA-2980736","Peptide hormone metabolism","1/29","42/2914",0.344970260386773,0.381931359713927,0.251039045555359,"CTNNB1",1
"R-HSA-5617833","R-HSA-5617833","Cilium Assembly","1/29","42/2914",0.344970260386773,0.381931359713927,0.251039045555359,"PLK1",1
"R-HSA-6783783","R-HSA-6783783","Interleukin-10 signaling","1/29","42/2914",0.344970260386773,0.381931359713927,0.251039045555359,"STAT3",1
"R-HSA-6798695","R-HSA-6798695","Neutrophil degranulation","2/29","125/2914",0.355471128383783,0.39255590259176,0.258022434155632,"MAPK1/MAPK14",2
"R-HSA-69239","R-HSA-69239","Synthesis of DNA","1/29","44/2914",0.35813407095819,0.394492859887956,0.259295573683328,"CDK2",1
"R-HSA-1226099","R-HSA-1226099","Signaling by FGFR in disease","1/29","45/2914",0.36461982424816,0.400620262591649,0.263323044293808,"STAT3",1
"R-HSA-5696399","R-HSA-5696399","Global Genome Nucleotide Excision Repair (GG-NER)","1/29","46/2914",0.371042279841329,0.405623046476415,0.266611316020152,"YY1",1
"R-HSA-69473","R-HSA-69473","G2/M DNA damage checkpoint","1/29","46/2914",0.371042279841329,0.405623046476415,0.266611316020152,"TP53",1
"R-HSA-1989781","R-HSA-1989781","PPARA activates gene expression","1/29","47/2914",0.377402033636518,0.410507475183581,0.269821794263281,"MED1",1
"R-HSA-877300","R-HSA-877300","Interferon gamma signaling","1/29","47/2914",0.377402033636518,0.410507475183581,0.269821794263281,"CIITA",1
"R-HSA-168643","R-HSA-168643","Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways","1/29","48/2914",0.38369967612851,0.414242933929785,0.272277067899519,"MAPK14",1
"R-HSA-400206","R-HSA-400206","Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)","1/29","48/2914",0.38369967612851,0.414242933929785,0.272277067899519,"MED1",1
"R-HSA-5693607","R-HSA-5693607","Processing of DNA double-strand break ends","1/29","48/2914",0.38369967612851,0.414242933929785,0.272277067899519,"CDK2",1
"R-HSA-186797","R-HSA-186797","Signaling by PDGF","1/29","49/2914",0.389935792455193,0.419930853413285,0.276015671295174,"STAT3",1
"R-HSA-69306","R-HSA-69306","DNA Replication","1/29","51/2914",0.402225760659776,0.431027111423068,0.283309112771408,"CDK2",1
"R-HSA-8951664","R-HSA-8951664","Neddylation","1/29","51/2914",0.402225760659776,0.431027111423068,0.283309112771408,"HIF1A",1
"R-HSA-1632852","R-HSA-1632852","Macroautophagy","1/29","53/2914",0.414276513981962,0.441759231125728,0.290363210368839,"CSNK2A1",1
"R-HSA-397014","R-HSA-397014","Muscle contraction","1/29","53/2914",0.414276513981962,0.441759231125728,0.290363210368839,"PAK1",1
"R-HSA-168249","R-HSA-168249","Innate Immune System","5/29","428/2914",0.425598072936076,0.451034548051504,0.296459768425801,"MAPK1/MAPK14/MAPK3/PAK1/CTNNB1",5
"R-HSA-163685","R-HSA-163685","Integration of energy metabolism","1/29","55/2914",0.426092545394278,0.451034548051504,0.296459768425801,"STK11",1
"R-HSA-5696398","R-HSA-5696398","Nucleotide Excision Repair","1/29","55/2914",0.426092545394278,0.451034548051504,0.296459768425801,"YY1",1
"R-HSA-1500931","R-HSA-1500931","Cell-Cell communication","1/29","57/2914",0.437678266550349,0.462171210907182,0.303779767537827,"CTNNB1",1
"R-HSA-111885","R-HSA-111885","Opioid Signalling","1/29","59/2914",0.449038009201073,0.4707306666504,0.309405798356193,"MAPK1",1
"R-HSA-202403","R-HSA-202403","TCR signaling","1/29","59/2914",0.449038009201073,0.4707306666504,0.309405798356193,"PAK1",1
"R-HSA-5693567","R-HSA-5693567","HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)","1/29","59/2914",0.449038009201073,0.4707306666504,0.309405798356193,"CDK2",1
"R-HSA-416482","R-HSA-416482","G alpha (12/13) signalling events","1/29","61/2914",0.460176026587112,0.480087489275978,0.315555929162721,"ROCK2",1
"R-HSA-9612973","R-HSA-9612973","Autophagy","1/29","61/2914",0.460176026587112,0.480087489275978,0.315555929162721,"CSNK2A1",1
"R-HSA-6806834","R-HSA-6806834","Signaling by MET","1/29","62/2914",0.465663196313356,0.484647067625891,0.318552887040059,"STAT3",1
"R-HSA-5693538","R-HSA-5693538","Homology Directed Repair","1/29","63/2914",0.471096494808066,0.489128896523207,0.321498741105479,"CDK2",1
"R-HSA-376176","R-HSA-376176","Signaling by ROBO receptors","1/29","64/2914",0.476476432251267,0.493534061090811,0.324394204597647,"PAK1",1
"R-HSA-416476","R-HSA-416476","G alpha (q) signalling events","2/29","165/2914",0.495461683800429,0.511977073260443,0.336516582230367,"MAPK1/MAPK3",2
"R-HSA-69242","R-HSA-69242","S Phase","1/29","71/2914",0.512683772856071,0.528514863229299,0.347386679444919,"CDK2",1
"R-HSA-5621481","R-HSA-5621481","C-type lectin receptors (CLRs)","1/29","72/2914",0.517654638345756,0.532374675455114,0.349923689178598,"PAK1",1
"R-HSA-193704","R-HSA-193704","p75 NTR receptor-mediated signalling","1/29","76/2914",0.537052992938812,0.549719337111897,0.361324133779588,"HDAC1",1
"R-HSA-3858494","R-HSA-3858494","Beta-catenin independent WNT signaling","1/29","76/2914",0.537052992938812,0.549719337111897,0.361324133779588,"CTNNB1",1
"R-HSA-1430728","R-HSA-1430728","Metabolism","3/29","289/2914",0.56014157653786,0.572003398158661,0.375971188214885,"CSNK2A1/STK11/MED1",3
"R-HSA-388396","R-HSA-388396","GPCR downstream signalling","4/29","436/2914",0.650349325519615,0.662562458393223,0.435494606414173,"MAPK1/MAPK3/PAK1/ROCK2",4
"R-HSA-73887","R-HSA-73887","Death Receptor Signalling","1/29","106/2914",0.660359352690417,0.671184915849276,0.441162047526446,"HDAC1",1
"R-HSA-3247509","R-HSA-3247509","Chromatin modifying enzymes","1/29","109/2914",0.670777775487939,0.677017568748292,0.444995782514642,"HDAC1",1
"R-HSA-4839726","R-HSA-4839726","Chromatin organization","1/29","109/2914",0.670777775487939,0.677017568748292,0.444995782514642,"HDAC1",1
"R-HSA-8953854","R-HSA-8953854","Metabolism of RNA","1/29","109/2914",0.670777775487939,0.677017568748292,0.444995782514642,"MAPK14",1
"R-HSA-5663205","R-HSA-5663205","Infectious disease","1/29","126/2914",0.724234179795342,0.729275252972572,0.479344151238339,"CTNNB1",1
"R-HSA-372790","R-HSA-372790","Signaling by GPCR","4/29","486/2914",0.737604107650355,0.74101894148207,0.487063141260347,"MAPK1/MAPK3/PAK1/ROCK2",4
"R-HSA-1280218","R-HSA-1280218","Adaptive Immune System","2/29","296/2914",0.809917214629713,0.81178769318544,0.533578619581019,"PAK1/PPP2R5C",2
"R-HSA-418594","R-HSA-418594","G alpha (i) signalling events","1/29","217/2914",0.895178891815974,0.895178891815974,0.588390685622433,"MAPK1",1
